Sponsor Pipeline

Shanghai Zhimeng Biopharma, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07095855 A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB Chronic Hepatitis B Not Yet Recruiting
Phase 2/3
NCT07082192 A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult… ALS (Amyotrophic Lateral Sclerosis) Not Yet Recruiting
Phase 2
NCT07238868 An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in… Focal Epilepsy Recruiting
NCT06612775 A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients… Focal Epilepsy Not Yet Recruiting
Disease Areas
Epilepsy (2) ALS (1)
Get alerts when Shanghai Zhimeng Biopharma, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free